Enzymatic and metabolic studies with allopurinol.
作者信息
Elion G B
出版信息
Ann Rheum Dis. 1966 Nov;25(6 Suppl):608-14. doi: 10.1136/ard.25.Suppl_6.608.
Abstract
摘要
相似文献
1
Enzymatic and metabolic studies with allopurinol.使用别嘌呤醇的酶学和代谢研究。
Ann Rheum Dis. 1966 Nov;25(6 Suppl):608-14. doi: 10.1136/ard.25.Suppl_6.608.
2
Metabolic studies of allopurinol, an inhibitor of xanthine oxidase.黄嘌呤氧化酶抑制剂别嘌醇的代谢研究。
Biochem Pharmacol. 1966 Jul;15(7):863-80. doi: 10.1016/0006-2952(66)90163-8.
3
[Inhibition of xanthine oxidase by allopurinol (1 H-5 dihydro-4,5 pyrazolo (3,4-d)pyrimidinone-4) (study of the oxidation process and the effect of aminomethylation)].别嘌呤醇（1H - 5 - 二氢 - 4,5 - 吡唑并[3,4 - d]嘧啶酮 - 4）对黄嘌呤氧化酶的抑制作用（氧化过程及氨甲基化效应的研究）
C R Acad Hebd Seances Acad Sci D. 1971 Jan 25;272(4):639-42.
4
Purine N-oxides. XXX. Biochemical studies of the oncogen 3-hydroxyxanthine.
J Biol Chem. 1969 Aug 10;244(15):4072-6.
5
Allopurinol in patients with impaired renal function.肾功能受损患者使用别嘌醇。
Ann Rheum Dis. 1966 Nov;25(6 Suppl):681-7. doi: 10.1136/ard.25.Suppl_6.681.
6
Metabolic aspects of purine N-oxide derivatives.
Xenobiotica. 1971 Jul-Oct;1(4):361-3. doi: 10.3109/00498257109041502.
7
The effect of allopurinol on oxypurine excretion in xanthinuria.别嘌醇对黄嘌呤尿症中氧嘌呤排泄的影响。
J Rheumatol. 1976 Jun;3(2):201-4.
8
Allopurinol in the therapy of neoplasia and blood diseases. Metabolic aspects.别嘌醇在肿瘤和血液疾病治疗中的应用。代谢方面。
Ann Rheum Dis. 1966 Nov;25(6 Suppl):657-9. doi: 10.1136/ard.25.Suppl_6.657.
9
Allopurinol in the prevention of hyperuricaemia secondary to the treatment of neoplastic diseases with alkylating agents, adrenal steroids, and radiation therapy.别嘌醇在预防因使用烷化剂、肾上腺皮质类固醇和放射疗法治疗肿瘤性疾病继发的高尿酸血症中的应用。
Ann Rheum Dis. 1966 Nov;25(6 Suppl):651-4. doi: 10.1136/ard.25.Suppl_6.651.
10
Catabolism of some cytotoxic purine derivatives by xanthine oxidase and peroxidase.
Biochem Pharmacol. 1967 Sep 9;16(9):1747-55. doi: 10.1016/0006-2952(67)90250-x.
引用本文的文献
1
The anti-hyperuricemia potential of bioactive natural products and extracts derived from traditional Chinese medicines: A review and perspective.中药来源的生物活性天然产物及提取物的抗高尿酸血症潜力：综述与展望
J Pharm Anal. 2025 Jul;15(7):101183. doi: 10.1016/j.jpha.2024.101183. Epub 2025 Jan 3.
2
Dysuricemia.排尿障碍血症
Biomedicines. 2023 Nov 28;11(12):3169. doi: 10.3390/biomedicines11123169.
3
Computational Characterization of the Inhibition Mechanism of Xanthine Oxidoreductase by Topiroxostat.托匹司他对黄嘌呤氧化还原酶抑制机制的计算表征
ACS Catal. 2023 May 5;13(9):6023-6043. doi: 10.1021/acscatal.3c01245. Epub 2023 Apr 18.
4
Investigation of the Inhibition Mechanism of Xanthine Oxidoreductase by Oxipurinol: A Computational Study.黄嘌呤氧化酶抑制剂别嘌呤醇抑制机制的研究：计算研究。
J Chem Inf Model. 2023 Jul 10;63(13):4190-4206. doi: 10.1021/acs.jcim.3c00624. Epub 2023 Jun 15.
5
Medicinal fungus alleviates gout by modulating TLR4/NF-kB/NLRP3 signaling.药用真菌通过调节TLR4/NF-κB/NLRP3信号通路缓解痛风。
Front Pharmacol. 2022 Oct 21;13:1011406. doi: 10.3389/fphar.2022.1011406. eCollection 2022.
6
Synthesis and biological evaluation of thiazolidine-2-thione derivatives as novel xanthine oxidase inhibitors.噻唑烷-2-硫酮衍生物的合成及生物评价作为新型黄嘌呤氧化酶抑制剂。
PLoS One. 2022 May 18;17(5):e0268531. doi: 10.1371/journal.pone.0268531. eCollection 2022.
7
Association of Mutations Identified in Xanthinuria with the Function and Inhibition Mechanism of Xanthine Oxidoreductase.黄嘌呤尿症中鉴定出的突变与黄嘌呤氧化还原酶的功能及抑制机制的关联
Biomedicines. 2021 Nov 20;9(11):1723. doi: 10.3390/biomedicines9111723.
8
Inhibitory Effects of Quercetin and Its Human and Microbial Metabolites on Xanthine Oxidase Enzyme.槲皮素及其人体和微生物代谢物对黄嘌呤氧化酶的抑制作用。
Int J Mol Sci. 2019 May 31;20(11):2681. doi: 10.3390/ijms20112681.
9
Urate-lowering therapy alleviates atherosclerosis inflammatory response factors and neointimal lesions in a mouse model of induced carotid atherosclerosis.降尿酸治疗可减轻诱导颈动脉粥样硬化小鼠模型的动脉粥样硬化炎症反应因子和新生内膜病变。
FEBS J. 2019 Apr;286(7):1346-1359. doi: 10.1111/febs.14768. Epub 2019 Feb 9.
10
The possible antianginal effect of allopurinol in vasopressin-induced ischemic model in rats.别嘌醇在大鼠血管加压素诱导的缺血模型中可能的抗心绞痛作用。
Saudi Pharm J. 2015 Oct;23(5):487-98. doi: 10.1016/j.jsps.2014.12.001. Epub 2015 Jan 7.
Zotero 插件